Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Do β2-agonists inhibit capsaicin-induced cough?

N. Ohkura, M. Fujimura, A. Tokuda, N. Katayama
European Respiratory Journal 2010 36: 459-460; DOI: 10.1183/09031936.00057410
N. Ohkura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nori@med3.m.kanazawau.ac.jp
M. Fujimura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Tokuda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Katayama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

We read with great interest the paper by Freund-Michel et al. 1 in a recent issue of the European Respiratory Journal, because the results are inconsistent with the medical common sense that β2-agonists do not have common antitussive property.

The authors showed that a β2-agonist, terbutaline (0–3 mg·kg−1), dose-dependently inhibited 10−4 M capsaicin-induced cough in conscious guinea pigs. Terbutaline also blocked sensory nerve activation. They concluded that β2-agonists are antitussive and directly inhibit sensory nerve activation.

We have shown that the number of 10−4 M capsaicin-induced coughs was extremely increased 24 h after an antigen challenge in sensitised guinea pigs, and a β2-agonist, procaterol (0.1 mg·kg−1), did not alter the increased cough response to capsaicin. In addition, procaterol did not influence the cough response to capsaicin in naïve guinea pigs. We concluded that airway allergy accompanied with airway eosinophilia induces transient increase in cough reflex sensitivity, which is not mediated by bronchoconstriction 2.

The discrepancy between these two studies may result from difference of methods to measure cough response in conscious guinea pigs. Freund-Michel et al. 1 exposed capsaicin (10−4 M) for 5 min and measured the number of coughs for 10 min. However, we exposed capsaicin (10−4 M) for 2 min and measured the number of coughs for 3 min.

In order to elucidate the different results, we actually measured the number of coughs using the method described by Freund-Michel et al. 1. Guinea pigs were assigned to one of two groups: a control group and a procaterol group (n = 6 for each group). Procaterol (0.1 mg·kg−1) was administered 30 min prior to exposure to capsaicin. The results are shown in figure 1. There was no difference in the number of coughs during the initial 3-min period between the two groups: the mean number of coughs was 4 in the control group and 3.7 in the procaterol group. This result was the same as our previous results. On the other hand, the number of coughs during the 10-min period in the procaterol group was significantly decreased compared with that in the control group: the mean number of coughs was 6.8 in the procaterol group and 11 in the control group (p = 0.028). This finding was the same as those of Freund-Michel et al. 1. Thus, it is concluded that both our previous results and the results of Freund-Michel et al. 1 are scientifically correct. It is very important to recognise that methods for evaluating cough response in guinea pigs strongly influence the results, and standardisation of the methods should be established in order to be translated to clinical practice.

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Cumulative number of coughs in conscious guinea pigs. Guinea pigs were exposed to aerosolised capsaicin (10−4 M) for 5 min and the number of coughs was measured for 10 min after the initiation of capsaicin exposure. Guinea pigs were assigned to one of two groups: the control group (•) and procaterol group (▴), n = 6 for each group. Data are presented as mean±sem. *: p<0.05 versus control group.

Footnotes

  • Statement of Interest

    None declared.

    • ©ERS 2010

    REFERENCES

    1. ↵
      1. Freund-Michel VC,
      2. Birrell MA,
      3. Giembycz MA,
      4. et al
      . β2-agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway. Eur Respir J 2010; 35: 647–654.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      1. Liu Q,
      2. Fujimura M,
      3. Tachibana H,
      4. et al
      . Characterization of increased cough sensitivity after antigen challenge in guinea pigs. Clin Exp Allergy 2001; 31: 474–484.
      OpenUrlCrossRefPubMedWeb of Science
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 36 Issue 2 Table of Contents
    European Respiratory Journal: 36 (2)
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Do β2-agonists inhibit capsaicin-induced cough?
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    Do β2-agonists inhibit capsaicin-induced cough?
    N. Ohkura, M. Fujimura, A. Tokuda, N. Katayama
    European Respiratory Journal Aug 2010, 36 (2) 459-460; DOI: 10.1183/09031936.00057410

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Do β2-agonists inhibit capsaicin-induced cough?
    N. Ohkura, M. Fujimura, A. Tokuda, N. Katayama
    European Respiratory Journal Aug 2010, 36 (2) 459-460; DOI: 10.1183/09031936.00057410
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Footnotes
      • REFERENCES
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Non-animal models for COVID-19 lung research
    • User-life of ICS/LABA inhaler devices should be considered
    • Peripheral blood eosinophil counts in European and East Asian populations
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • CME
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Submit a manuscript
    • ERS author centre

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2021 by the European Respiratory Society